GENECAPTURE SBIR Phase II Award, June 2020

Modern airmen and other Warfighters face the threat of widespread infections, multidrug resistant bacteria and biothreat agents. In order to provide accurate front-line diagnosis in return-to-duty/quarantine scenarios, a rapid and robust test is needed that can withstand the rigors of transport and forward environments. GeneCapture, Inc. is responding to this need with our patented diagnostic system. Our mission is to diagnose up to 200 pathogens from a single patient sample in 45 minutes for less than $20 on evacuation transports, in field hospitals and during special operation missions.